Spampcin (56鈥?6), Spa31

General Information


DRACP ID  DRACP04547

Peptide Name   Spampcin (56鈥?6), Spa31

Sequence  RRAAHGLLPRLRAPPPFHKRCVCLCRTAPPP

Sequence Length  31

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C154H256N54O33S3

Absent amino acids  DEIMNQSWY

Common amino acids  P

Mass  402353

Pl  12.21

Basic residues  9

Acidic residues  0

Hydrophobic residues  10

Net charge  9

Boman Index  -6824

Hydrophobicity  -40.97

Aliphatic Index  72.58

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  125

Absorbance 280nm  4.17

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 36362111

Title  A Novel Antimicrobial Peptide Spampcin56-86 from Scylla paramamosain Exerting Rapid Bactericidal and Anti-Biofilm Activity In Vitro and Anti-Infection In Vivo

Doi Not available

Year  2022

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  20541

DRACP is developed by Dr.Zheng's team.